The microRNA miR-21 conditions the brain to protect against ischemic and traumatic injuries
- PMID: 34268484
- PMCID: PMC8279043
The microRNA miR-21 conditions the brain to protect against ischemic and traumatic injuries
Abstract
Ischemic and traumatic injuries to CNS remain leading causes of death and disability worldwide, despite decades of research into risk factors, therapies, and preventative measures. Recent studies showed that CNS injuries significantly alter the cerebral microRNAome that impact the secondary brain damage as well as plasticity and recovery. Many microRNA based therapies are currently in various clinical trials for different pathologic conditions indicating their therapeutic potential. In the present review, we discuss the role of miR-21 in acute CNS injuries which is currently thought to be a potent neuroprotective microRNA. We emphasize on the potential of miR-21 in promoting cell and tissue survival and preventing inflammation and apoptosis. We also discussed the role of miR-21 in conditioning the brain to promote ischemic tolerance. Finally, we discussed some of the challenges and difficulties to develop miR-21 as a neuroprotective therapy in humans.
Keywords: CNS injury; Stroke; miR-21; neuroprotection; therapy.
Figures
![Figure 1:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dae7/8279043/6a3758502cfe/nihms-1607370-f0001.gif)
Similar articles
-
MicroRNA-146a down-regulation correlates with neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro.Brain Res. 2016 Oct 1;1648(Pt A):136-143. doi: 10.1016/j.brainres.2016.07.034. Epub 2016 Jul 20. Brain Res. 2016. PMID: 27449900
-
miR-150-3p enhances neuroprotective effects of neural stem cell exosomes after hypoxic-ischemic brain injury by targeting CASP2.Neurosci Lett. 2022 May 14;779:136635. doi: 10.1016/j.neulet.2022.136635. Epub 2022 Apr 15. Neurosci Lett. 2022. PMID: 35436510
-
IGF-1/IGF-R Signaling in Traumatic Brain Injury: Impact on Cell Survival, Neurogenesis, and Behavioral Outcome.In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 7. In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 7. PMID: 26269893 Free Books & Documents. Review.
-
The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury.Int J Mol Sci. 2019 Dec 23;21(1):120. doi: 10.3390/ijms21010120. Int J Mol Sci. 2019. PMID: 31878035 Free PMC article. Review.
-
MicroRNA-based therapeutics in central nervous system injuries.J Cereb Blood Flow Metab. 2018 Jul;38(7):1125-1148. doi: 10.1177/0271678X18773871. Epub 2018 Apr 30. J Cereb Blood Flow Metab. 2018. PMID: 29708005 Free PMC article. Review.
Cited by
-
Commentary: Can astrocytic mitochondria therapy be used as antioxidant conditioning to protect neurons?Cond Med. 2022 Dec;5(6):192-195. Cond Med. 2022. PMID: 38037662 Free PMC article.
-
Therapeutic Potential of Intravenous miR-21 Mimic after Stroke Following STAIR Criteria.Transl Stroke Res. 2023 Dec 22:10.1007/s12975-023-01223-8. doi: 10.1007/s12975-023-01223-8. Online ahead of print. Transl Stroke Res. 2023. PMID: 38129636
-
Deciphering the Role of microRNAs: Unveiling Clinical Biomarkers and Therapeutic Avenues in Atrial Fibrillation and Associated Stroke-A Systematic Review.Int J Mol Sci. 2024 May 20;25(10):5568. doi: 10.3390/ijms25105568. Int J Mol Sci. 2024. PMID: 38791605 Free PMC article. Review.
-
Post-stroke cognitive impairment: exploring molecular mechanisms and omics biomarkers for early identification and intervention.Front Mol Neurosci. 2024 May 23;17:1375973. doi: 10.3389/fnmol.2024.1375973. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38845616 Free PMC article. Review.
-
Potential mechanisms underlying the association between type II diabetes mellitus and cognitive dysfunction in rats: a link between miRNA-21 and Resveratrol's neuroprotective action.Metab Brain Dis. 2022 Oct;37(7):2375-2388. doi: 10.1007/s11011-022-01035-z. Epub 2022 Jul 4. Metab Brain Dis. 2022. PMID: 35781592 Free PMC article.
References
-
- Baek J, Kang S, Min H (2014) MicroRNA-targeting therapeutics for hepatitis C. Archives of pharmacal research 37:299–305. - PubMed
-
- Barbosa AC, Kim MS, Ertunc M, Adachi M, Nelson ED, McAnally J, Richardson JA, Kavalali ET, Monteggia LM, Bassel-Duby R, Olson EN (2008) MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proceedings of the National Academy of Sciences of the United States of America 105:9391–9396. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources